If they were going to RS it would have been done in October... Liquidity will not return with a RS and time it would rocket back to 0. Better to start at bottom with one way up.. Mrkt cap less than 1 million, plenty of room for this fledgling biotech.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.